| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,022 | 1,567 | 2,015 | 1,604 | | Cost of Revenue | 870 | 713 | 915 | 611 | | | Gross Profit | 1,152 | 854 | 1,100 | 993 | | | Operating Expenses | | Research Development | 507 | 464 | 380 | 386 | | Selling General and Administrative | 2,578 | 2,353 | 2,511 | 2,946 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 274 | 409 | 417 | 351 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,207) | (2,372) | (2,208) | (2,690) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 94 | 100 | 113 | 136 | | Earnings Before Interest And Taxes | (2,113) | (2,272) | (2,095) | (2,554) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,113) | (2,272) | (2,095) | (2,554) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,113) | (2,272) | (2,095) | (2,554) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,113) | (2,272) | (2,095) | (2,554) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,113) | ($2,272) | ($2,095) | ($2,554) |
|
0.02% Nasdaq 
Income Statement
